Journals / Turkish Neurosurgery / 2012 / Cilt: 22 - Sayı: 6

Gliom tedavisinde 1H-MR spektroskopi rehberliğinde gamma bıçağı radyocerrahisi

1H-MR spectroscopy guided gamma knife radiosurgery for treatment of glioma

Pages
690–694
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

ConclusIon: The MRS-guided gamma knife radiosurgery helps to identify and remove the lesion of glioma and reduce complications due to extended surgical scope.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To observe the outcomes of 1H- MR-spectroscopy (MRS) guided gamma knife surgery for treatment of glioma.
📊
Key Findings & Data:The target volume was defined as the tumor enhanced area plus the surrounding area with a short T1 and a long T2 in the MRI group, while the tumor enhanced area plus the surrounding area with a short T1 and a long T2 and choline: N-acetyl aspartate index (CNI)≥1.6 in the MRI plus MRS group.12 months after surgery were set as the endpoint.
💡
Conclusion & Impact:ConclusIon: The MRS-guided gamma knife radiosurgery helps to identify and remove the lesion of glioma and reduce complications due to extended surgical scope.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIM: To observe the outcomes of 1H- MR-spectroscopy (MRS) guided gamma knife surgery for treatment of glioma. MaterIal and Methods: Twenty patients with glioma diagnosed pathologically were randomly divided into MRI group and MRI plus MRS group. The target volume was defined as the tumor enhanced area plus the surrounding area with a short T1 and a long T2 in the MRI group, while the tumor enhanced area plus the surrounding area with a short T1 and a long T2 and choline: N-acetyl aspartate index (CNI)≥1.6 in the MRI plus MRS group.12 months after surgery were set as the endpoint. Results: Thirteen (65%) patients were successfully treated, of whom 6 were in the MRI group and 7 in the MRI plus MRS group. Ten patients suffered from cerebral edema during treatment, including 8 in the MRI group and 2 in the other group. The cases of cerebral edema were significantly fewer in the MRI plus MRS group than the MRI group. The average maximum diameter of the target volume was smaller in the MRI plus MRS group. ConclusIon: The MRS-guided gamma knife radiosurgery helps to identify and remove the lesion of glioma and reduce complications due to extended surgical scope.

Özet

AMAÇ: Gliom tedavisinde 1H-MR spektroskopi (MRS) rehberliğinde gamma bıçağı cerrahisinin sonuçlarını değerlendirmek. YÖNTEM ve GEREÇLER: Patolojik olarak gliom tanısı konmuş yirmi hasta MRG grubu ve MRG artı MRS grubu olarak rastgele bölündü. Hedef hacim tümör kontrast madde tutan alanı artı çevresindeki MRG grubunda kısa T1 ve uzun T2 alan olarak değerlendirilirken MRG artı MRS grubunda ise tümör kontrast madde tutan alanı artı çevresindeki kısa T1 ve uzun T2 ve kolin:N-asetil aspartat indeksi (CNI)≥1,6 olan alandı. Cerrahiden 12 ay sonrası son nokta olarak belirlendi. BULGULAR: On üç (%65) hasta başarıyla tedavi edildi ve bunların 6’sı MRG grubunda ve 7’si MRG artı MRS grubundaydı. On hasta tedavi sırasında serebral ödem yaşadı ve bunların 8’i MRG grubunda ve 2’si diğer gruptaydı. Serebral ödem vakalarının sayısı MRG artı MRS grubunda MRG grubundan önemli ölçüde daha azdı. Hedef hacmin ortalama maksimum çapı MRG artı MRS grubunda daha küçüktü. SONUÇ: MRS rehberli gamma bıçağı radyocerrahisi gliom lezyonunun tanımlanması ve çıkarılmasına ve genişletilmiş cerrahi kapsam sayesinde komplikasyonların azalmasına yardımcı olur.

🔖

Cite This Article

SHEN, G., XU, L., XU, M., GENG, M., TAN, Y., LI, F. (2012). Gliom tedavisinde 1H-MR spektroskopi rehberliğinde gamma bıçağı radyocerrahisi. Turkish Neurosurgery, Cilt: 22 - Sayı: 6, 690–694. https://ajindex.com/articles/405030

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Alexander A, Murtha A, Abdulkarim B, Mehta V, Wheatley M, Murray B, Riauka T, Hanson J, Fulton D, McEwan A, Roa W: Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma. Clin Invest Med 29:301-311, 2006 2. Burger PC, Heinz ER, Shibata T, Kleihues P: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68:698-704, 1998 3. Cha S: Neuroimaging in neuro-oncology. Neurotherapeutics 6:465-477, 2009 4. Chuang CF, Chan AA, Larson D, Verhey LJ, McDermott M, Nelson SJ, Pirzkall A: Potential value of MR spectroscopic imaging for the radiosurgical management of patients with recurrent high-grade gliomas. Technol Cancer Res Treat 6:375-382, 2007 5. Sheehan J, Xu Z: Stereotactic Radiosurgery for recurrent high grade gliomas. World Neurosurgery 76:61-62, 2011 6. Gruber S, Stadlbauer A, Mlynarik V, Gatterbauer B, Roessler K, Moser E: Proton magnetic resonance spectroscopic imaging in brain tumor diagnosis. Neurosurg Clin N Am 16:101-114, 2005 7. Goldman S, Pirotte BJ: Brain tumors. Methods Mol Biol 727:291-315, 2011 8. Henderson MA, Fakiris AJ, Timmerman RD, Worth RM, Lo SS, Witt TC: Gamma knife stereotactic radiosurgery for low- grade. Astrocytomas Stereotact Funct Neurosurg 87:161-167, 2009 9. Kalapurakal JA, Silverman CL, Akhtar N, Laske DW, Braitman LE, Boyko OB, Thomas PR: Intracranial meningiomas: Factors that influence the development of cerebral edema after stereotactic radiosurgery and radiation therapy. Radiology 204:461-465, 1997 10. Kida Y, Yoshimoto M, Hasegawa T: Radiosurgery for intracra- nial gliomas. Prog Neurol Surg 22:122-128, 2009 11. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D: Glioma grading: Sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989-1998, 2003 12. McKnight TR, von dem Bussche MH, Vigneron DB, Lu Y, Berger MS, McDermott MW, Dillon WP, Graves EE, Pirzkall A, Nelson SJ: Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97:794-802, 2002 13. Pirzkall A, McKnight TR, Graves EE, Carol MP, Sneed PK, Wara WW, Nelson SJ, Verhey LJ, Larson DA: MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50:915-928, 2003 14. Soares DP, Law M: Magnetic resonan